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Published byDecreasing youth tobacco use is a signiﬁcantpublic health priority. In the U.S., nearly onein 15 middle school students and one in four
high school students were current tobacco users in 2012,1
and 5.6 million youth aged under 18 years today are
projected to die prematurely from smoking-related dis-
ease.2 The Family Smoking Prevention and Tobacco
Control Act (FSPTCA), signed into law on June 22,
2009, amended the Federal Food Drug and Cosmetic Act
(FD&C Act) to provide the U.S. Food and Drug Admin-
istration (FDA) with the authority to regulate the
manufacturing, distribution, and marketing of tobacco
products to protect public health. In writing the Act,
Congress recognized the critical importance of adoles-
cent tobacco use in propagating the tobacco use epi-
demic, noting that “the use of tobacco products by the
Nation’s children is a pediatric disease of considerable
proportions that results in new generations of tobacco-
dependent children and adults” and “virtually all new
users of tobacco products are under the minimum legal
age to purchase such products.”
The protection of adolescents is also reﬂected in the
standard that the FDA must use in the regulation of
tobacco products. Unlike the “safe and effective” stan-
dard used to regulate drugs and devices, the FDA is
required to use a population health standard to regulate
tobacco products. This standard requires the FDA, in
making regulatory decisions, to assess not only the
impacts on current tobacco product users but also those
on never users and former users. One of the earliest
regulatory actions of the FDA was the issuance of a
ﬁnal rule restricting the sale and distribution of cigar-
ettes and smokeless tobacco. This rule, intended to
protect children and adolescents, set a minimum agece of Science, Center for Tobacco Products, U.S. Food and
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purchases; and prohibited the sale of single cigarettes;
free samples of cigarettes (and restricted free samples of
smokeless tobacco); tobacco brand name sponsorship of
sporting, cultural, and musical events; and the sale or
distribution of non-tobacco items with tobacco brands
or logos.3
In February 2014, the FDA also launched its ﬁrst youth
tobacco prevention campaign, “The Real Cost.” This
campaign targets at-risk youth aged 12–17 years who are
susceptible to smoking or already experimenting with
cigarettes. The objective of the campaign is to educate
these at-risk youth about the harmful effects of tobacco
use in order to build awareness, change attitudes and
beliefs, alter behavioral intent, and ultimately reduce
current smoking among adolescents. Additional cam-
paigns are planned, including one aimed at rural
smokeless tobacco users, a multicultural campaign, and
a campaign aimed at the lesbian, gay, bisexual, and
transgender communities.
FDA and CDC Partnership to Enhance
Youth Tobacco Surveillance
Monitoring and assessing tobacco use and the factors
that inﬂuence use among youth will help inform effective
programs, policies, and regulations for tobacco use
prevention and control. In order to inform and monitor
the impact of the FDA’s efforts and assess progress
toward achieving one of its core public health goals,
preventing youth tobacco use, the FDA entered into a
partnership with the CDC to expand the National Youth
Tobacco Survey (NYTS). The NYTS is the only nation-
ally representative survey of middle and high school
students that focuses exclusively on tobacco use and its
correlates. The CDC, the lead public health surveillance
agency in the U.S., has conducted the NYTS on a regular
basis since 1999. These data have been used to inform
and evaluate the CDC’s National Comprehensive
Tobacco Control Program, inform progress toward
achieving Healthy People 2020 goals related to tobacco
and youth, provide data to inform the USDHHS’se Medicine Am J Prev Med 2014;47(2S1):S1–S3 S1
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national benchmark data for state-level Youth Tobacco
Surveys and comparison with the international commu-
nity through the Global Youth Tobacco Survey.
In collaboration with the CDC, the FDA identiﬁed the
need for comprehensive, annual data on tobacco use
among youth to help inform and evaluate the impacts of
FDA tobacco regulatory activities. In order to minimize
unnecessary duplication and redundancy, the FDA and
CDC are collaborating to leverage this surveillance
system for our nation’s public health goals by moving
to annual surveys. The annual ﬁelding has resulted in the
ability to timely identify emerging trends, such as the
increased use of electronic cigarettes (e-cigarettes)
observed between 2011 and 2012.1
In 2012, the FDA and CDC introduced questions to
the survey speciﬁcally related to FDA’s regulatory
authority, including more detailed information on the
use of non-conventional (e.g., e-cigarettes, hookah)
tobacco products, curiosity about cigarettes, cigars,
and smokeless tobacco, tobacco dependence symptoms,
quitting intentions and behaviors around all tobacco
products, harm perceptions of conventional and non-
conventional products, and awareness and perception
of product warning labels. The studies presented in this
supplement reﬂect a focus on these questions of
particular relevance to informing federal tobacco pro-
duct regulation.
Highlights from the Supplement
The ﬁndings reported in this supplement highlight the
changing landscape of tobacco product use among U.S.
adolescents in middle and high school. The majority of
middle and high school current tobacco users report past
30-day use of more than one product. This high degree of
polytobacco use has important implications for the
likelihood of maintaining tobacco use into adulthood.
Apelberg et al.4 examined the prevalence of four symp-
toms of tobacco dependence in adolescent tobacco users
and found that polytobacco use was one of the most
consistent predictors of reported symptoms, after con-
trolling for frequency of use, age at ﬁrst use, and
demographic factors. Apelberg and colleagues4 also
report results consistent with a growing body of evidence
that symptoms of tobacco dependence can arise even
among recent-onset and intermittent adolescent users.
Among adolescent cigarette, cigar, and smokeless
tobacco users, more than half reported at least one
symptom of tobacco dependence, representing 2 million
middle and high school students. Signiﬁcant differences
in symptom reporting were found when com-
paring those who used on as few as 3–5 days comparedwith 1–2 days in the past month. These ﬁndings high-
light the need for tobacco prevention efforts aimed both
at non-users and experimenters in order to prevent
tobacco use.
The ﬁndings presented in this supplement also point
to the growing concern surrounding the use of non-
cigarette tobacco products. Presently, the FDA has
regulatory authority over cigarettes, smokeless tobacco,
and roll-your-own tobacco. In April 2014, the FDA
issued a proposed rule to extend its authority over all
other tobacco products, including cigars, hookah, and
e-cigarettes. Cigars are the second most widely used
tobacco product among youth and, among certain
subgroups (e.g., female non-Hispanic blacks), is more
prevalent than cigarette smoking. Corey et al.5 report on
the high burden of cigar use among U.S. youth in 2012,
ﬁnding that the inclusion of cigar brand names on the
survey questions may have improved ascertainment of
cigar smoking. In addition, Portnoy and colleagues6
report that about one in ﬁve adolescents who had never
used tobacco products were curious about the use of
cigars, a predictor of future susceptibility, experimenta-
tion, and regular use.
Recent studies conducted using the NYTS have raised
public health concerns about the increase in e-cigarette
use in youth7 and the high degree of dual use with
cigarette smoking.8 Wang et al.9 build on this work by
characterizing patterns of e-cigarette use in the context of
other non-conventional products and highlight the wide-
spread awareness of e-cigarettes among youth. Ambrose
and colleagues10 examined perceptions about the harm of
e-cigarettes, ﬁnding that one in three students perceived
these products as less harmful than conventional cigar-
ettes and a signiﬁcant association between ever use of e-
cigarettes and lower perceptions of risk. The authors also
found that youth who perceive the harmfulness of
conventional cigarettes as dose-dependent were more
likely to perceive e-cigarettes as less harmful, which may
make them susceptible to future e-cigarette experimenta-
tion and use, either alone or in conjunction with
cigarettes. Wang et al.9 also found a high degree of
awareness of hookah among youth and prevalence of
ever and current hookah use that exceeded both e-
cigarettes and conventional smokeless products. Tworek
and colleagues11 found that hookah users were the least
likely to intend to quit tobacco and make a past year quit
attempt among all tobacco product users, which may
suggest a lack of awareness of the harmfulness of these
products among youth.
The FDA’s tobacco regulatory authority includes
authority over the marketing and labeling of tobacco
products, including tobacco product warning labels. In
this supplement, Tessman et al.12 ﬁnd that youthwww.ajpmonline.org
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direct mail coupons, which serve both as a source of
marketing and price discounting. Exposure to tobacco
marketing has consistently been associated with youth
susceptibility, and, in Portnoy and colleagues’ study,6 was
found to be associated with curiosity to use cigarettes,
cigars, and smokeless tobacco. Finally, Johnson et al.13
report on youth exposure to cigarette and smokeless
tobacco product warning labels, ﬁnding that less than
half of adolescents who saw a pack reported high
exposure to the warnings and less than one third who
saw a warning reported that it made them think a lot
about health risks. These ﬁndings are consistent with the
widely held belief that current warning labels are not as
effective as they could be and that strengthening the
warning labels would beneﬁt public health.
Conclusions
The FD&C Act provides the FDA with important new
regulatory tools to reduce the toll of tobacco use in
the U.S., which can complement recommended tobacco
control efforts at the local, state, and national level.14
Given that the overwhelming majority of adult tobacco
users began using as youth, preventing youth tobacco use
remains a major public health priority. The FDA and
CDC are collaborating to leverage the NYTS to meet the
nation’s public health goals by collecting national data on
tobacco susceptibility, experimentation, and use among
middle and high school students, along with the factors
that inﬂuence use, such as exposure to tobacco marketing
and health warnings, harm perceptions, and symptoms
of tobacco dependence. The studies presented in this
supplement highlight areas of particular relevance to the
FDA’s regulatory authority and add to the evidence base
to inform tobacco regulatory science and tobacco control
efforts nationwide.
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